BeOne Medicines
ONC
#691
Rank
NZ$58.38 B
Marketcap
NZ$505.40
Share price
-2.12%
Change (1 day)
18.61%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: NZ$58.38 Billion

As of March 2026 BeOne Medicines has a market cap of NZ$58.38 Billion. This makes BeOne Medicines the world's 691th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$58.38 B-2.18%
2025NZ$59.68 B64.37%
2024NZ$36.31 B16.5%
2023NZ$31.17 B-22.18%
2022NZ$40.05 B-1.55%
2021NZ$40.68 B24.04%
2020NZ$32.80 B116.22%
2019NZ$15.17 B21.77%
2018NZ$12.45 B98.83%
2017NZ$6.26 B260.33%
2016NZ$1.73 B

End of Day market cap according to different sources

On Mar 10th, 2026 the market cap of BeOne Medicines was reported to be:

NZ$57.28 Billion
by Nasdaq info icon info icon
NZ$59.65 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
OPKO Health
OPK
NZ$1.50 B-97.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ$35.34 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA